| Tretinoin | Approved Investigational Nutraceutical | IL1B | 3553 |
upregulated | Tretinoin results in increased expression of IL1B mRNA | 2q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | IL1R1 | 3554 |
upregulated | Tretinoin results in increased expression of IL1R1 mRNA | 2q11.2-q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | IL1RN | 3557 |
upregulated | Tretinoin results in increased expression of IL1RN mRNA | 2q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | IL2 | 3558 |
downregulated | Tretinoin results in decreased expression of IL2 mRNA | 4q27 | |
| Tretinoin | Approved Investigational Nutraceutical | IL20RA | 53832 |
downregulated | Tretinoin results in decreased expression of IL20RA mRNA | 6q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IL24 | 11009 |
downregulated | Tretinoin metabolite results in decreased expression of IL24 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | IL24 | 11009 |
downregulated | Tretinoin results in decreased expression of IL24 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | IL4 | 3565 |
upregulated | Tretinoin results in increased expression of IL4 mRNA | 5q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | IL5 | 3567 |
upregulated | Tretinoin results in increased expression of IL5 mRNA | 5q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | IL5RA | 3568 |
downregulated | Tretinoin results in decreased expression of IL5RA mRNA | 3p26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | IL6 | 3569 |
downregulated | Tretinoin results in decreased expression of IL6 mRNA | 7p15.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IL6ST | 3572 |
upregulated | Tretinoin results in increased expression of IL6ST mRNA | 5q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ILF3 | 3609 |
downregulated | Tretinoin results in decreased expression of ILF3 mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ILK | 3611 |
upregulated | Tretinoin results in increased expression of ILK mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | ILKAP | 80895 |
downregulated | Tretinoin results in decreased expression of ILKAP mRNA | 2q37.3 | |
| Tretinoin | Approved Investigational Nutraceutical | IMMP1L | 196294 |
downregulated | Tretinoin results in decreased expression of IMMP1L mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | IMP4 | 92856 |
downregulated | Tretinoin results in decreased expression of IMP4 mRNA | 2q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | IMPA2 | 3613 |
downregulated | Tretinoin results in decreased expression of IMPA2 mRNA | 18p11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | IMPDH1 | 3614 |
downregulated | Tretinoin results in decreased expression of IMPDH1 mRNA | 7q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | IMPDH2 | 3615 |
upregulated | Tretinoin results in increased expression of IMPDH2 mRNA | 3p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | INA | 9118 |
downregulated | Tretinoin results in decreased expression of INA mRNA | 10q24.33 | |
| Tretinoin | Approved Investigational Nutraceutical | INF2 | 64423 |
downregulated | Tretinoin results in decreased expression of INF2 mRNA | 14q32.33 | |
| Tretinoin | Approved Investigational Nutraceutical | INHBA | 3624 |
upregulated | Tretinoin results in increased expression of INHBA mRNA | 7p14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | INHBB | 3625 |
downregulated | Tretinoin results in decreased expression of INHBB mRNA | 2q14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | INHBC | 3626 |
downregulated | Tretinoin results in decreased expression of INHBC mRNA | 12q13.3 | |